PipeBio

acquiredunknown
unknown
Stage
4
Investors

About

PipeBio is a cloud-based bioinformatics software platform designed for antibody, TCR, and peptide sequence analysis, enabling scientists to automate workflows, store and compare sequences, and perform antibody engineering.

Explore PipeBio's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.